Searched for
BDR PHARMACEUTICALS DIRECTOR
Baton of leadership: Next-gen business heirs rewrite the rulebookIndia's family businesses are in the midst of a renaissance, driven by the ambitious next generation. Emerging leaders are championing inno...- BDR Pharmaceuticals plans $100 mn expansion in the US with manufacturing buyoutsBDR Pharmaceuticals is set to broaden its presence in the US through acquisitions of manufacturing facilities, backed by a $100 million inv...
- Isha, Akash Ambani, Alakh Pandey in Hurun's under-35 list of entrepreneurs shaping India's economic futureReliance Retail's Isha Ambani and Parita Parekh from Toddle are the youngest women in the inaugural 2024 Hurun India Under35s list. The lis...
- BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution formIt is a more patient-friendly way to tackle prostate cancer. It can help improve patient compliance to a great extent, Badiger said. The co...
- BDR Pharma CMD’s family buys luxury apartments in Mumbai’s Worli for Rs 81 crThe performance in terms of stamp duty collection led by the heightened activity in premium and mid-income housing segments have also pushe...
- BDR Pharmaceutical launches generic drug for treating prostate cancer in IndiaBDR Group Director Business Development Raheel Shah said that the launch of APATIDE is "testimony towards our commitment in providing acces...
- Generic drug companies in no hurry to launch new Covid productsBDR Pharmaceuticals, a Mumbai-based active pharmaceutical ingredient (API) manufacturing company, has developed the API of antiviral pill P...
- Mankind, BDR Pharma join hands to launch anti COVID-19 pill MolulifeMankind Pharma on Wednesday said it has joined hands with BDR Pharmaceuticals to launch oral anti-COVID-19 pill Molulife (Molnupiravir) in ...
- USFDA approves COVID antiviral pill molnupiravir for emergency useThe USFDA also said the drug should be given for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or cl...
- BDR Pharma inks licensing pact with Eli Lilly for COVID-19 treatment drugBaricitinib has received restricted emergency use approval, for use in combination with Remdesivir, for treatment of suspected or laborator...
- Indian drug companies start off a price war on experimental Covid-19 drugOver the next few weeks, close to 10 drug companies including Abbott, Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr Reddy...
- Hetero, Cipla to supply generic Remdesivir to hospitals this weekThe recommended course for a Covid-19 patient under oxygen support is five vials. The approved therapy is for moderate to severe patients.
- Delhi HC Upholds BMS' Patent for Cancer Drug DasatinibThe Delhi High Court has upheld the patent of US-based BMS for Dasatinib, dashing the hopes of a local company to sell a generic version of...
- Delhi High Court upholds BMS’ patent for cancer drug DasatinibThe Indian Patent Office had in 2013 rejected the company’s demand for a compulsory licence as it did not follow the procedures for obtaini...
- Dose of bitter pills, few booster injections for pharma sectorThe pharma sector, estimated to be around Rs 1.5 lakh cr, recorded single digit growth for the first time in many years on account of deepe...
- Government rejects BDR Pharma's CL application for anti-cancer drugUnder the Indian Patents Act, if a medicine is deemed unaffordable, a compulsory licence can be issued to a generic drug maker in public in...
- Patent office rejects BDR Pharma’s compulsory licensing applicationThe Patent Office rejected BDR’s application on the grounds that the company did not make enough efforts to obtain a voluntary licence for ...
- Roselabs in talks with pharma majors to supply pre-filled syringesRoselabs Bioscience said it is in talks with some of the large Hyderabad-based pharma, biotech firms including Dr Reddy’s Labs and Bharat B...
Load More
